Expertise in
5
conditions

Helena M. Isoniemi

Helsinki, FI 
Expertise in
5
conditions
Helsinki, FI 

Overview

Helena Isoniemi practices practicing medicine in Helsinki, Finland.

Ms. Isoniemi is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sclerosing Cholangitis, Colorectal Cancer, Cholangitis, Liver Transplant, and Hepatectomy.

She is actively involved in clinical research, co-authoring 96 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Helsinki, Finland
Other Locations
Box, 00029, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase 2 Study of Bevacizumab in Combination with Alternating XELIRI and XELOX As First-line Treatment of Patients with Metastatic Colorectal Cancer
Phase 2 Study of Bevacizumab in Combination with Alternating XELIRI and XELOX As First-line Treatment of Patients with Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 12, 2024
Intervention Type: Drug
Study Phase: Phase 2
Donor Specific HLA Alloantibodies in Liver Transplantation: a Prospective Blinded Multicenter Prognostic Study
Donor Specific HLA Alloantibodies in Liver Transplantation: a Prospective Blinded Multicenter Prognostic Study
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Other
Activation of Coagulation Pathways in Clinical Renal Allotransplantation and Delayed Graft Function and Acute Rejection of the Graft
Activation of Coagulation Pathways in Clinical Renal Allotransplantation and Delayed Graft Function and Acute Rejection of the Graft
Enrollment Status: Unknown
Publish Date: March 29, 2018
View 2 Less Clinical Trials

96 Total Publications

Preformed donor-specific class II DQ antibodies are associated with graft loss after liver transplantation: A prospective multicenter study.
Preformed donor-specific class II DQ antibodies are associated with graft loss after liver transplantation: A prospective multicenter study.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: March 18, 2026

Frequently Asked Questions about Helena M. Isoniemi

Is Helena M. Isoniemi a top-rated expert for Liver Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Helena M. Isoniemi is classified as an Distinguished expert for Liver Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Helena M. Isoniemi participate in research or clinical trials?

Yes. Helena M. Isoniemi has published 96 articles and abstracts on conditions like Liver Transplant. You can view a list of Helena M. Isoniemi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Isoniemi's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile